7 October 2024
In
Cost-Volume, Medicines, Pharma
Alexandra Stoicescu – Future directions in contractual mechanisms facilitating access to medicines
Ensuring access to innovative medicines for the population is a key objective, recognized at both the European level[1] and at the national level[2], acting as a genuine impetus for national authorities to develop a legal framework that is equally properly aligned with this aim. However,